Mentoring: It’s Not Just a LinkedIn Title Mentoring is having a moment. If you’ve scrolled through LinkedIn recently,

Overall survival (OS) has long been considered the gold standard in oncology trials. Defined as the time from treatment initiation

Probability of Pricing and Access Success (PPAS) is an emerging metric that evaluates the likelihood of a drug achieving favorable

Probability of Technical Success (PTS) is a metric that evaluates the likelihood that a drug candidate will successfully navigate clinical

The MSCI World Pharmaceuticals, Biotechnology, and Life Sciences Index (USD) is a key benchmark for the biotech and pharmaceutical industry.

Killing a project is easy. There’s a laundry list of reasons why something “shouldn’t move forward”: it’s

LinkedIn profiles boasting titles like ex-McKinsey, ex-Bain, ex-Novartis, or ex-Roche. It’s as if these professionals are collecting exes, not in their personal lives (well, hopefully), but in their résumés, brandishing them like badges of honor.

In European boardrooms, where modesty often masquerades as pragmatism, it is rare for a leader to sound the alarm with

The Problem with Probability of Success (POS) in Biotech and Pharma Probability of Success (POS) is a widely used metric

Few metrics in modern oncology trials command the prominence of progression-free survival (PFS). As a measure of time until disease